Sofinnova Investments, Inc. Celldex Therapeutics, Inc. Transaction History

Sofinnova Investments, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$32.76 - $42.56 $8.32 Million - $10.8 Million	-254,070 Reduced 31.69%	547,707 $20.3 Million
Q1 2024 Aug 14, 2024	BUY	$35.22 - $51.88 $8.95 Million - $13.2 Million	254,070 Added 46.39%	801,777 $33.7 Million
Q1 2024 May 15, 2024	SELL	$35.22 - $51.88 $1.49 Million - $2.19 Million	-42,231 Reduced 5.0%	801,777 $33.7 Million
Q4 2023 Aug 15, 2024	BUY	$22.61 - $40.65 $6.7 Million - $12 Million	296,301 Added 54.1%	844,008 $33.5 Million
Q4 2023 Feb 12, 2024	BUY	$22.61 - $40.65 $14.6 Million - $26.3 Million	646,250 Added 326.79%	844,008 $33.5 Million
Q2 2023 Aug 14, 2023	SELL	$30.29 - $38.28 $6.71 Million - $8.48 Million	-221,639 Reduced 52.85%	197,758 $6.71 Million
Q1 2023 May 11, 2023	BUY	$34.78 - $47.43 $14.6 Million - $19.9 Million	419,397 New	419,397 $15.1 Million
Q2 2022 Aug 15, 2022	BUY	$20.5 - $37.33 $990,232 - $1.8 Million	48,304 New	48,304 $1.3 Million
Q1 2022 May 16, 2022	SELL	$27.64 - $39.32 $7.51 Million - $10.7 Million	-271,533 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $4.8 Million - $7.57 Million	134,501 Added 98.15%	271,533 $10.5 Million
Q3 2021 Nov 15, 2021	BUY	$28.95 - $55.99 $66,816 - $129,224	2,308 Added 1.71%	137,032 $7.4 Million
Q2 2021 Aug 16, 2021	BUY	$20.71 - $35.37 $2.79 Million - $4.77 Million	134,724 New	134,724 $4.51 Million

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.22B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.